Mitokinin

Mitokinin is focused on developing small molecule drugs targeting PINK1 for the treatment of neurodegenerative diseases, particularly Parkinson's disease

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceuticals

Model

01Company Overview

Mitokinin is focused on developing small molecule drugs targeting PINK1 for the treatment of neurodegenerative diseases, particularly Parkinson's disease.

02Backed By1 investor

MBMission BioCapital→

03Similar Companies